A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseases
Arcellx, Inc.
Arcellx, Inc.
Brain Inflammation Collaborative
Tongji Hospital
Tianjin Huanhu Hospital
The First People's Hospital of Changzhou
Fondazione Policlinico Universitario Agostino Gemelli IRCCS